中文名称:BCMA抗体 英文名称:Anti BCMA 品牌: 百普赛斯 产地: 北京 保存条件: -20°C to -70°C 纯度规格: 99.9% 产品类别: 抗体 抗体名: BCMA 靶点: BCMA 宿主: HEK293 适应物种: 人/鼠 克隆性: 单克隆 Anti-BCMA Neutralizing Antibody, Mouse IgG1 (recommended for neutralizing assay) 抗体来源(...
抗体名:BCMA 是否单克隆:是 靶点:BCMA 用途:生物制药 宿主:HEK293 保质期:12个月 产地:北京 包装规格:100ug 品牌:ACRO 适应物种:人/鼠/猴等 克隆性:是 保存条件:-20°C to -70°C 货号:BCMA 是否进口:否 Anti-BCMA Neutralizing Antibody, Mouse IgG1 (recommended for neutralizing assay) ...
Anti-BCMA Antibody是一类可以特异性结合BCMA的多克隆抗体,主要用于检测BCMA的Western Blot、IHC-P、IF、ELISA、Co-IP等多种免疫学实验。 检测原理:双抗体夹心法测定标本中BCMA水平。用纯化的BCMA抗体包被微孔板,制成固相抗体,往包被单抗的微孔中依次加入BCMA,再与HRP标记的BCMA抗体结合,形成抗体-抗原-酶标抗体...
Recent data suggest a suboptimal antibody response to COVID-19 vaccination in patients with hematological malignancies, especially under immunosuppressive therapy. Herein, we evaluated the development of neutralizing antibodies (NAbs) against SARS-CoV-2 in patients with plasma cell neoplasms after ...
However, 20% of patients experienced a rebound in pso- riasis symptoms 2 weeks after CMAB001 discontinuation. Anti-antibody and neutralizing anti-antibody antibody No anti-antibody antibodies or neutralizing anti-antibody antibodies were detected. Discussion Antibodies to LFA-1 or its ligands that ...
Neutralizing monoclonal antibody against human IFN-γ Anti-hIFN-γ-hIgA2 (clone H7WM120) is arecombinantmonoclonal antibody (mAb) able to neutralize human interferon-gamma (hIFN-γ). This mAbis expressed and produced in chinese hamster ovary (CHO) cells, ensuring reliability and lot-to-lot repro...
CD20 CHO Recombinant Cell Line (High or Medium Expression)Anti-CD20 CAR-T CellsAnti-PD-1 Neutralizing AntibodyAnti-CD20-Anti-CD3 Bispecific AntibodyAnti-CD20-Anti-CD3 IgM format Bispecific AntibodyBCMA / CD20 / Firefly Luciferase CHO Cell Line ...
. A combination of anti-CD3 and rTGF-β alone and in presence of neutralizing anti-TGF-β was included as a control. Each symbol represents an individual cell type. Horizontal lines correspond to mean ± SEM. Data were calculated with one-way ANOVA with Tukey’s correction (a,b) and ...
Previously, obstruction of VEGF receptor 2 (VEGFR2)150 and its downstream signaling pathways, BCL-2 and Survivin,151 via small-molecule inhibitors or neutralizing antibodies has shown success in blocking tumor growth and prolonging survival. However, limitations, such as temporary efficacy, treatment ...
Second, we tested the efficacies of an mTOR inhibitor (Torin 1), a mitogen-activated protein kinase (MAPK) inhibitor (PD98059) and a neutralizing antibody against E-cadherin on cancer cells in BICA, IVBL or 2D cultures. Both the mTOR inhibitor and anti-E-cadherin treatment significantly inhib...